Better Outcome of Off-Label High-Dose Ceftazidime in Hemato-Oncological Patients with Infections Caused by Extensively Drug-Resistant Pseudomonas Aeruginosa .
Mediterranean journal of hematology and infectious diseases（2023）
摘要
Ceftazidime in high doses is a very potent antibiotic (ATB) for treating XDR infections in neutropenic cancer with acceptable toxicity.
更多查看译文
关键词
Ceftazidime,Neutropenia,XDR P. aeruginosa infection
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要